Clinical Trial Update: The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS [Phase 2]

View source ↗

Summary

Phase 2 trial results assessing the safety and effectiveness of FIAC for cytomegalovirus infection in patients with AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Cytomegalovirus Infection
• HIV Infection

Drugs mentioned

• FIAC

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Infections, HIV Infections | Phase 2 | Status: COMPLETED